Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 21,150 shares at $80.09 ($1.7M) on 2017-03-22, disclosed to the SEC on 2017-03-24.
Open-market sale of $1.7M EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.09 | 7,100 | $569K | 33.0% |
| 2 | $82.06 | 7,025 | $576K | 33.5% |
| 3 | $82.06 | 7,025 | $576K | 33.5% |
| Total | $81.40 avg | 21,150 | $1.7M | 100% |
| Filing → |
| EGRX | SELL | 2016-12-02 | $479K | — | Filing → |
| EGRX | SELL | 2015-06-18 | $814K | — | Filing → |